NCT00130754View on ClinicalTrials.gov

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

November 30, 2007

Conditions
Stem Cell TransplantationGraft Vs Host Disease
Interventions
DRUG

Thymoglobuline

IV 7.5 mg/kg

Trial Locations (1)

91120

Hadassah Medical Organization, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT00130754 - Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation | Biotech Hunter | Biotech Hunter